Neuroprotective Effects of Psychotropic Drugs in Huntington’s Disease

Psychotropics (antipsychotics, mood stabilizers, antidepressants, anxiolytics, etc.) are commonly prescribed to treat Huntington’s disease (HD). In HD preclinical models, while no psychotropic has convincingly affected huntingtin gene, HD modifying gene, or huntingtin protein expression, psychotropi...

Descripción completa

Detalles Bibliográficos
Autor principal: Lauterbach, Edward C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856079/
https://www.ncbi.nlm.nih.gov/pubmed/24248060
http://dx.doi.org/10.3390/ijms141122558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856079/
https://www.ncbi.nlm.nih.gov/pubmed/24248060
http://dx.doi.org/10.3390/ijms141122558

Ejemplares similares